Charles Carter

Charles Carter

Finansdirektör/CFO på OVID THERAPEUTICS INC.

Förmögenhet: 26 700 $ per 2026-08-31

59 år
Health Technology
Consumer Services
Technology Services

Profil

Charles R.
Carter
is Chief Financial & Accounting Officer, Secretary at Ovid Therapeutics, Inc. since 2026.
Former roles include Chief Financial Officer, Secretary & Treasurer at CERo Therapeutics Holdings, Inc. in 2024; Chief Financial Officer, Secretary & Treasurer at Morphic Medical, Inc. from 2018 to 2021; Chief Financial Officer at The Guild For Human Services from 2015 to 2018; Chief Financial Officer & Secretary at iCAD, Inc. from 2021 to 2022; Chief Financial Officer at Intelligent Medical Devices, Inc.; Principal at Adnexus; Partner at Mercer Management Consulting, Inc.; Chief Financial Officer at Aeris Therapeutics LLC; and Senior Director-Financial Planning & Analysis at Shire Human Genetic Therapies, Inc. Education includes undergraduate studies at Colgate University and graduate studies including an MBA at The University of Chicago.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
2026-07-06 10 000 ( 0,01 % ) 26 700 $ 2026-08-31

Aktiva positioner av Charles Carter

FöretagPositionStart
OVID THERAPEUTICS INC. Finansdirektör/CFO 2026-07-06

Tidigare kända positioner av Charles Carter

FöretagPositionSlut
ICAD Finansdirektör/CFO 2022-05-20
GI DYNAMICS, INC. Finansdirektör/CFO 2021-04-01
Finansdirektör/CFO 2018-02-01
Företagsledare/Principal -
Se detaljerna i Charles Carters erfarenhet

Charles Carters utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

35

Första gradens relationer

11

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag11

Health Technology

Health Technology

Health Technology

Technology Services

Commercial Services

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Services

  1. Börsen
  2. Insiders
  3. Charles Carter
SENASTE TIDEN | -40%: De bästa verktygen för prenumeranter för att identifiera morgondagens bästa investeringar!
d
:
:
TA DEL AV DET NU